Grove Bank & Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
JC
WCG
FWCM
BRCM
IWA
NRS
ACM
WPC
GI
FFA
Grove Bank & Trust's EW Position: Q3 2026 in Review
Grove Bank & Trust held its Edwards Lifesciences (EW) position steady in Q3 2026 at 1,009 shares worth $87.1K. The position accounts for 0.01% of the portfolio, ranked #373.
Grove Bank & Trust first reported a position in EW in Q4 2016 and has held it in 21 quarters since. The position peaked at $91.3K in Q2 2026. 54 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Grove Bank & Trust held 1,009 shares of Edwards Lifesciences worth $87.1K as of Q3 2026.
- Grove Bank & Trust left its Edwards Lifesciences share count unchanged in Q3 2026.
- Edwards Lifesciences made up 0.01% of Grove Bank & Trust's portfolio in Q3 2026, its #373 holding.
- Grove Bank & Trust first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 21 quarters since.
- Grove Bank & Trust's Edwards Lifesciences position peaked at $91.3K in Q2 2026.
- 54 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Grove Bank & Trust's 13F filing for Q3 2026, filed 8 Oct 2026.